We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Repurposing Drugs for the Treatment of Multi-Drug Resistant Breast Cance
Poster

Repurposing Drugs for the Treatment of Multi-Drug Resistant Breast Cance

Repurposing Drugs for the Treatment of Multi-Drug Resistant Breast Cance
Poster

Repurposing Drugs for the Treatment of Multi-Drug Resistant Breast Cance

In this study, the Johns Hopkins Clinical Compound Library, containing approximately 1,500 FDA and foreign-approved clinical compounds, was used to screen a multi-drug resistant, triple negative breast cancer cell line for drug sensitivity.

Advertisement